Cargando…
Management of Osteoporosis in Chronic Kidney Disease
Chronic kidney disease (CKD) patients with coexisting osteoporosis are becoming common. Many of the therapeutic agents used to treat osteoporosis are known to be affected by the renal function. It is generally thought that osteoporosis in G1 to G3 CKD patients can be treated as in non-CKD patients w...
Autores principales: | Nitta, Kosaku, Yajima, Aiji, Tsuchiya, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790712/ https://www.ncbi.nlm.nih.gov/pubmed/29021477 http://dx.doi.org/10.2169/internalmedicine.8618-16 |
Ejemplares similares
-
Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018) -
Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease
por: Nitta, Kosaku
Publicado: (2010) -
Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
por: Nitta, Kosaku
Publicado: (2010) -
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
por: Sugiura, Hidekazu, et al.
Publicado: (2018) -
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)